Indraprastha Medical Corporation Ltd. (INDRAMEDCO) 52 Week Low Streak: Extended Breakdown Continues

Indraprastha Medical Corporation Ltd. has now set a fresh 52-week low for its second straight session, extending a cumulative decline of 2.86% across the streak. The latest trough stands at Rs 327.45, while the current price is Rs 329.05. Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

With a market capitalisation of Rs 3,062.79 crore, this repeated-low pattern matters more than a single-day break below the yearly floor. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak signals that the stock has remained under pressure across consecutive sessions, so readers should track the next close, the cumulative move across the streak and whether the stock can stabilise above the latest trough.

Indraprastha Medical Corporation Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 329.05
Previous Close	Rs 334.1
Today's Move	Rs -5.05 (-1.51%)
Open	Rs 331.7
High	Rs 334.5
Low	Rs 327.45
Market Capitalisation	Rs 3,062.79 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) traded at Rs 329.05 versus the previous close of Rs 334.1, a fall of 1.51%. The stock opened at Rs 331.7, reached a high of Rs 334.5, touched a low of Rs 327.45.

Indraprastha Medical Corporation Ltd. finished at Rs 329.05, compared with the previous close of Rs 334.10, which means the stock declined by Rs 5.05 or 1.51% in the latest session. The day opened at Rs 331.70, touched an intraday high of Rs 334.50 and a low of Rs 327.45, and closed close to the lower end of that range. The stock’s latest close also matched the fresh 52-week low, reinforcing the Indraprastha Medical Corporation Ltd. 52 Week Low Streak rather than interrupting it.

The session range was narrow enough to keep attention on the closing level, because the finish sat well below the opening print and beneath the previous close. Market capitalisation stood at Rs 3,062.79 crore, which places the stock in the current market context without changing the fact that the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is being defined by repeated yearly lows, not by one isolated session. The cumulative decline of 2.86% across the streak is the more important read for this article than the one-day move alone.

What the Repeated 52-Week Lows Show

The Indraprastha Medical Corporation Ltd. 52 Week Low Streak tells readers that the stock has not merely slipped once; it has continued to print a new one-year low on each of the last two sessions. That pattern is important because it shows continuity in weakness across sessions, even though the latest Univest data does not identify a company-specific trigger. In other words, the streak itself is the signal.

For a reader tracking the Indraprastha Medical Corporation Ltd. 52 Week Low Streak, the key numbers are simple. The stock has fallen 2.86% across the streak and is now sitting at Rs 327.45 as the latest 52-week low. The previous session established the first break, and the latest session confirmed that the decline has not yet been reversed. This is why a streak-based read is more useful than a one-day headline.

Another way to view the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is that the stock has remained unable to reclaim the prior session’s floor. That keeps the focus on whether the next session merely matches the low again or finally closes above it. Until that happens, the streak remains the dominant market fact.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,062.79 crore
P/E Ratio	16.29x
P/B Ratio	3.85x
ROE	27.47%
ROCE	37.7%
EPS	Rs 20.51
Book Value Per Share	Rs 86.85
Dividend Yield	1.2%

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) fundamental metrics show P/E 16.29x, P/B 3.85x, ROE 27.47%, ROCE 37.7%. Taken on their own, these numbers offer context rather than a trading signal.

Indraprastha Medical Corporation Ltd. has a market capitalisation of Rs 3,062.79 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.29x, P/B at 3.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.47% and ROCE of 37.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.51, book value per share of Rs 86.85, dividend yield of 1.2%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 45.1x, median ROE of 12.95%, median ROCE of 15.83%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	16.29x
Benchmark Median P/E	45.1x
Benchmark Average P/E	98.5x
Benchmark P/E Range	6.78x to 1,588.84x
Company P/B Ratio	3.85x
Benchmark Median P/B	4.1x
Company ROE	27.47%
Benchmark Median ROE	12.95%
Company ROCE	37.7%
Benchmark Median ROCE	15.83%
Company Market Capitalisation	Rs 3,062.79 crore
Benchmark Median Market Cap	Rs 514.78 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 16.29x, which is below the benchmark median of 45.1x, a difference of -63.88%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROE of 27.47%, which is above the benchmark median of 12.95%, a difference of +112.12%. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROCE of 37.7%, which is above the benchmark median of 15.83%, a difference of +138.16%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
KMC Speciality Hospitals (India) Ltd.	KMCSHIL	2,761.84	49.52	12.17	24.94	27.25
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,504.42	32.86	6.77	25.22	29.21
SURAKSHA DIAGNOSTIC LIMITED	SURAKSHA	1,824.13	48.16	6.72	13.81	24.97
Krsnaa Diagnostics Ltd.	KRSNAA	1,798.4	18.61	1.83	10.97	13.08
Artemis Medicare Services Ltd.	ARTEMISMED	5,326.21	45.1	5.71	12.72	15.83

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 16.29x compared with the displayed peer median of 45.1x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.47% compares with a peer median of 13.81% across the companies shown in the table. ROCE stood at 37.7% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a market capitalisation of Rs 3,062.79 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

• The Indraprastha Medical Corporation Ltd. 52 Week Low Streak has now run for two straight sessions, so the pattern itself is the first thing to track.
• The cumulative decline of 2.86% across the streak gives a clearer read than the latest session alone.
• The latest low of Rs 327.45 is now the reference point for the next close and the next session’s behaviour.
• The stock’s P/E of 16.29 and P/B of 3.85 show how the streak has changed the pricing of the same earnings and book-value base.
• The company’s ROE and ROCE remain well above the industry medians, so the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is not the same thing as a deterioration in those ratios.

About the Company

Indraprastha Medical Corporation Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. For a reader following the Indraprastha Medical Corporation Ltd. 52 Week Low Streak, that business context matters because hospital operators are often analysed through a mix of valuation, profitability and market-cap scale. The current market capitalisation is Rs 3,062.79 crore, which helps place the stock in context without changing the basic streak narrative.

In this case, the business backdrop should be read alongside the price pattern rather than instead of it. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak remains the headline feature, while the company’s profitability ratios and earnings base explain why the market is pricing the stock the way it is today.

Track Indraprastha Medical Corporation Ltd. Share Price on Univest

Use Indraprastha Medical Corporation Ltd. (INDRAMEDCO) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Readers following the Indraprastha Medical Corporation Ltd. 52 Week Low Streak can continue to monitor the stock’s daily close, the latest yearly low and the cumulative move across the streak on Univest. The key is to watch whether the stock extends the pattern or begins to stabilise above the latest low of Rs 327.45.

For ongoing market tracking, the share price page also helps place the decline, valuation and sector comparison in one view.

Frequently Asked Questions

What does the Indraprastha Medical Corporation Ltd. 52 Week Low Streak mean?

Ans. It means the stock has set a fresh 52-week low on consecutive sessions. In this case, the Indraprastha Medical Corporation Ltd. 52 Week Low Streak has reached a second straight session, with the latest low at Rs 327.45.

How many sessions has the stock been making fresh 52-week lows?

Ans. The latest Univest data shows two consecutive sessions. That is why this is described as the Indraprastha Medical Corporation Ltd. 52 Week Low Streak rather than a one-day low event. The stock moved -1.51% during the session.

What is the latest 52-week low for the stock?

Ans. The latest 52-week low is Rs 327.45. That is also the level used in the Indraprastha Medical Corporation Ltd. 52 Week Low Streak analysis for the latest session. The stock moved -1.51% during the session.

Is a company-specific reason confirmed for the repeated lows?

Ans. No. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline in the Indraprastha Medical Corporation Ltd. 52 Week Low Streak.

How does the stock compare with the sector median on valuation?

Ans. The stock’s P/E of 16.29 is below the industry median of 45.1, and its P/B of 3.85 is slightly below the industry median of 4.1. That places the Indraprastha Medical Corporation Ltd. 52 Week Low Streak below the typical sector.

What profitability metrics stand out in the data?

Ans. ROE is 27.47% and ROCE is 37.7%, both well above the industry medians shown in the peer snapshot. Those figures are important in assessing the Indraprastha Medical Corporation Ltd. 52 Week Low Streak.

How should investors read the repeated low pattern?

Ans. The best reading is that the stock has remained under pressure across more than one session. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak is a pattern to monitor, not a conclusion about the next move.

What should investors track next?

Ans. They should watch whether the stock closes above Rs 327.45, whether the cumulative decline widens beyond 2.86%, and whether the Indraprastha Medical Corporation Ltd. 52 Week Low Streak extends to another session.